Skip to main content

Nexentis Technologies Inc.

corporate_fare Company Profile

Nexentis Technologies Inc.

NXTS·NASDAQ·Life Sciences·CIK 0001789192

Nexentis Technologies Inc., through its subsidiary, develops therapeutics for cancer and inflammatory metabolic diseases. The company operates through two segments: Biotechnology Activity and Renewable Energy Projects. Its product pipeline includes MITOLINE, an algorithm designed for multiple sequence/structure pairwise alignments to generate 3D comparative models of mitochondrial carrier proteins. The company also offers a cloud-based computational chemistry platform, novel in-vitro screening platforms, and advanced 3D NSCLC tumor spheroid systems. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel. The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026.

Nexentis Technologies Inc. (NASDAQ:NXTS) is a publicly traded company in the Life Sciences sector. Wiseek monitors NXTS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Nexentis Registers 2.57M Shares for Resale, Opening the Door to 177% Dilution from Recent Financings
  • Nexentis Secures $267K Liquidity from Partial Solar Asset Sale at $14.5M Valuation
  • Nexentis Finalizes Highly Dilutive $2.9M Offering at Deep Discount with Warrants
  • Nexentis Raises $2.9M in Highly Dilutive Offering, Adding More Warrants
  • Nexentis Technologies Secures $2.9M in Highly Dilutive Offering with Warrants at Deep Discount

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$4M
Diluted EPS
-$8.61
Op. Cash Flow
-$3.81M
Free Cash Flow
-$3.82M
Operating Income
-$4.23M
Cash & Equivalents
$3.83M
Total Debt
$1.21M
Debt / Equity
0.08×
Shares Outstanding
2.77M sh
Source: 10-K · filed 2026-03-31 · accession 0001493152-26-014183

Dilution Risk

Low risk

Filing-implied dilution signals for NXTS, detected from its recent SEC filings · based on capital-structure filings through 2026-07-13.

1 recent capital raise2 shelf registrations

Finalized $2.9 Million Offering · Deep Discount Pricing

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with N →
$1.52 -0.03% today
52-week range · as of 2026-07-13 $1.52 – $89.79
Market cap
$2.25M
Volume
610.5K (0.2× avg)
3-mo avg 2.7M
Live data · 2026-07-29 10:18 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed NXTS - Latest Insights

NXTS
Jul 13, 2026, 4:05 PM EDT
Filing Type: S-1
Importance Score:
8
Price at Filing: $3.10
Real-time Price: $1.52 info
Change: -$1.58 (-51%) info
Market Cap: $2.253M info
NXTS
Jun 29, 2026, 8:20 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.47
Real-time Price: $1.52 info
Change: -$3.95 (-72%) info
Market Cap: $2.253M info
NXTS
Jun 23, 2026, 10:03 AM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $5.96
Real-time Price: $1.52 info
Change: -$4.44 (-75%) info
Market Cap: $2.253M info
NXTS
Jun 22, 2026, 4:53 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $7.95
Real-time Price: $1.52 info
Change: -$6.43 (-81%) info
Market Cap: $2.253M info
NXTS
Jun 22, 2026, 4:49 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $9.00
Real-time Price: $1.52 info
Change: -$7.48 (-83%) info
Market Cap: $2.253M info
NXTS
Jun 22, 2026, 8:22 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $8.09
Real-time Price: $1.52 info
Change: -$6.57 (-81%) info
Market Cap: $2.253M info
NXTS
Jun 15, 2026, 6:02 AM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $4.80
Real-time Price: $1.52 info
Change: -$3.28 (-68%) info
Market Cap: $2.253M info
NXTS
Jun 12, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $4.80
Real-time Price: $1.52 info
Change: -$3.28 (-68%) info
Market Cap: $2.253M info
NXTS
Jun 12, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.80
Real-time Price: $1.52 info
Change: -$3.28 (-68%) info
Market Cap: $2.253M info
NXTS
May 27, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $4.90
Real-time Price: $1.52 info
Change: -$3.38 (-69%) info
Market Cap: $2.253M info
NXTS
May 27, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.90
Real-time Price: $1.52 info
Change: -$3.38 (-69%) info
Market Cap: $2.253M info
NXTS
May 18, 2026, 9:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.55
Real-time Price: $1.52 info
Change: -$3.03 (-67%) info
Market Cap: $2.253M info
NXTS
May 14, 2026, 4:27 PM EDT
Source: Wiseek News
Importance Score:
10
Price at Filing: $4.64
Real-time Price: $1.52 info
Change: -$3.12 (-67%) info
Market Cap: $2.253M info
NXTS
May 14, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $4.64
Real-time Price: $1.52 info
Change: -$3.12 (-67%) info
Market Cap: $2.253M info
NXTS
May 13, 2026, 7:07 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.57
Real-time Price: $1.52 info
Change: -$3.05 (-67%) info
Market Cap: $2.253M info
NXTS
Apr 16, 2026, 4:15 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $3.97
Real-time Price: $1.52 info
Change: -$2.45 (-62%) info
Market Cap: $2.253M info
NXTS
Apr 06, 2026, 8:39 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.670
Real-time Price: $1.52 info
Change: Reverse Stock Split info
Market Cap: $2.253M info
NXTS
Mar 31, 2026, 4:25 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.660
Real-time Price: $1.52 info
Change: Reverse Stock Split info
Market Cap: $2.253M info
NXTS
Mar 31, 2026, 4:16 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.660
Real-time Price: $1.52 info
Change: Reverse Stock Split info
Market Cap: $2.253M info
NXTS
Mar 17, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.761
Real-time Price: $1.52 info
Change: Reverse Stock Split info
Market Cap: $2.253M info